AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT by and among IMMUNOVANT SCIENCES LTD. AND ROIVANT SCIENCES LTD. Dated as of December 28, 2018Sharing and Cooperation Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of December 28, 2018 (the “Effective Date”), is entered into by and among Immunovant Sciences Ltd., a Bermuda exempted limited company (the “Company”), Roivant Sciences Ltd., a Bermuda exempted limited company (“Roivant”), and the Persons who from time to time become Shareholders of the Company in accordance with this Agreement and execute and deliver a Joinder Agreement, substantially as set forth on Exhibit A (a “Joinder Agreement”), (with each of the Company, Roivant and such Persons, individually, a “Party” and together, the “Parties”).
INFORMATION SHARING AND COOPERATION AGREEMENTSharing and Cooperation Agreement • May 11th, 2015 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
This Information Sharing and Cooperation Agreement, dated as of March 18, 2015 (this “Agreement”), is by and between Roivant Sciences Ltd., a Bermuda exempted company (“Roivant”), and Roivant Neurosciences Ltd., a Bermuda exempted company (“RNL”, with each of Roivant and RNL, a “Party” and together, the “Parties”).
INFORMATION SHARING AND COOPERATION AGREEMENT by and among UROVANT SCIENCES LTD., AND SUMITOVANT BIOPHARMA LTD. Dated as of May 21, 2020Sharing and Cooperation Agreement • May 28th, 2020 • Urovant Sciences Ltd. • Pharmaceutical preparations • New York
This INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of May 21, 2020 (the “Effective Date”), is entered into between Urovant Sciences Ltd., a Bermuda exempted limited company (the “Company”), and Sumitovant Biopharma Ltd., a Bermuda exempted limited company (“Sumitovant”) (with each of the Company and Sumitovant, a “Party” and, together, the “Parties”).
AMENDMENT NO. 1 TO INFORMATION SHARING AND COOPERATION AGREEMENTSharing and Cooperation Agreement • May 24th, 2019 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amendment No. 1 to that certain Information Sharing and Cooperation Agreement, dated as of July 6, 2016 (the “Original Agreement”), by and between Roivant Sciences Ltd., a Bermuda exempted company (“Roivant”), and Myovant Sciences Ltd., a Bermuda exempted company (“Myovant”), is entered into as of May 24, 2019 (the “Amendment”). Roivant and Myovant are referred to herein each as a Party and, together, as the Parties.
AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT by and among AXOVANT SCIENCES LTD., AND ROIVANT SCIENCES LTD. Dated as of June 5, 2018Sharing and Cooperation Agreement • August 7th, 2018 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
WHEREAS, the Parties wish to amend and restate the Original Agreement in its entirety, effective as of the Closing Date (as defined in that certain Share Purchase Agreement, dated as of June 5, 2018, by and between Roivant and the Company) (the “Effective Date”).
